Neuroprotective Goal Directed Hemodynamic Optimization in Post-cardiac Arrest Patients "NEUROPROTECT"


Phase N/A Results N/A

Summary of Purpose

The primary objective of the Neuroprotect trial is to assess whether or not a new goal directed hemodynamic optimization strategy can reduce cerebral ischemia in post-cardiac arrest (CA) patients.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 10 May 2016.

1 Aug 2015 27 Aug 2015 1 Dec 2017 1 Jul 2018 1 May 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment